tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics Positioned for Growth: Buy Rating Justified by Strategic Moves and Leadership Vision
PremiumRatingsArcutis Biotherapeutics Positioned for Growth: Buy Rating Justified by Strategic Moves and Leadership Vision
23d ago
Positive Outlook for Arcutis Biotherapeutics Amid Patent Litigation Developments and Market Exclusivity
Premium
Ratings
Positive Outlook for Arcutis Biotherapeutics Amid Patent Litigation Developments and Market Exclusivity
25d ago
Arcutis strategic valued enhanced by patent win, says H.C. Wainwright
Premium
The Fly
Arcutis strategic valued enhanced by patent win, says H.C. Wainwright
29d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Arcutis Biotherapeutics price target raised to $19 from $16 at Jefferies
Premium
The Fly
Arcutis Biotherapeutics price target raised to $19 from $16 at Jefferies
2M ago
Strong Recovery and Growth in Zoryve Prescriptions Boosts Buy Rating for Arcutis Biotherapeutics
Premium
Ratings
Strong Recovery and Growth in Zoryve Prescriptions Boosts Buy Rating for Arcutis Biotherapeutics
2M ago
Arcutis Biotherapeutics announces FDA accepted sNDA for ZORYVE
PremiumThe FlyArcutis Biotherapeutics announces FDA accepted sNDA for ZORYVE
2M ago
Arcutis Biotherapeutics: Strong Buy Rating Backed by Surpassing Sales and Promising Pipeline
Premium
Ratings
Arcutis Biotherapeutics: Strong Buy Rating Backed by Surpassing Sales and Promising Pipeline
2M ago
Strong Sales Growth and Financial Stability Drive Buy Rating for Arcutis Biotherapeutics
Premium
Ratings
Strong Sales Growth and Financial Stability Drive Buy Rating for Arcutis Biotherapeutics
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100